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Abstract 32 
Background: Chronic kidney disease (CKD) is a long-term medical condition 33 
associated with symptoms which may negatively impact on patients' health-related 34 
quality of life (HRQOL). Patient-reported outcome (PRO) measures or 35 
questionnaires may be used to capture symptoms/HRQOL experienced by patients 36 
with advanced CKD.  37 
Method: Two PRO questionnaires were electronically adapted and incorporated in 38 
an electronic system developed at University Hospitals Birmingham NHS Foundation 39 
Trust (UHB), Birmingham. Usability testing was conducted with patients with 40 
advanced CKD. Qualitative methodology was used to elicit participants’ views.  41 
Results: Participants had a mean age of 64.3 years (range: 36 - 87 years). All 42 
owned electronic devices and had access to the internet. The mean time required to 43 
complete the two electronic questionnaires was 15.9 minutes (range = 8-34 44 
minutes). Patients who had difficulties with the system were those who had the least 45 
experience of using the internet and electronic devices. The average usability and 46 
satisfaction score was 4.6 (5-point scale).  47 
Conclusions: Our study suggests that individuals with advanced CKD may find the 48 
Renal ePROM system acceptable and easy to use. The use of the Renal ePROM 49 
may complement clinician-reported outcomes and assist with the management of 50 
patients with advanced CKD.  51 
 52 
Keywords: usability testing; user testing; eHealth; electronic patient reported 53 
outcome measures; electronic system; chronic kidney disease; ePROM54 
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Introduction 55 
Chronic kidney disease (CKD) is a long-term medical condition associated with 56 
symptoms such as fatigue, pain and pruritus which may negatively impact on 57 
patients’ health-related quality of life (HRQOL).[1-3] While the use of clinician-58 
reported outcomes is essential in the management of patients with CKD, relying 59 
exclusively on these clinical parameters may underestimate the impact of the 60 
disease and its treatment on patients’ HRQOL.[4, 5] A patient-reported outcome 61 
(PRO) is defined as “any report of the status of a patient’s health condition that 62 
comes directly from the patient, without interpretation of the patient’s response by a 63 
clinician or anyone else.”[6, 7] Self-reported questionnaires, known as patient-64 
reported outcome measures (PROMs), are standardized instruments designed  to 65 
capture PRO information.[6, 7] PROM data could complement clinical parameters 66 
and inform the management of patients with advanced CKD.[4, 8]  67 
Traditionally, PROMs have been administered using a paper-based format.[9] 68 
However, in recent years, there has been a widespread interest in adapting and 69 
developing PROMs for electronic administration via telephone (interactive voice 70 
response) or screen-text devices [10] such as desktop and laptop computers, tablets 71 
and smartphones.  72 
The use of electronic PROMs (ePROMs) may facilitate the remote monitoring of 73 
patients’ symptoms/HRQOL and provide clinicians the opportunity to initiate timely 74 
interventions to delay disease progression.[11-13] Additional benefits may include: a 75 
lower administrative burden, increased acceptance rates, prevention of secondary 76 
data entry errors, and lower incidence of missing data.[9, 10, 14]  77 
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In Denmark, the generic ePROM system, AmbuFlex, has been successfully 78 
implemented for tailoring the care of various patient groups including patients with 79 
renal failure [15, 16] while the Advanced Symptom Management System (ASyMS) 80 
and the eRAPID system have been successfully used in the UK to monitor the side 81 
effects of chemotherapy.[17, 18]  82 
It is essential that the usability of an ePROM system is formally assessed during 83 
development to ensure it is fit for purpose.[10, 19] The International Organization for 84 
Standardization (ISO) defines usability as "The extent to which a product can be 85 
used by specified users to achieve specified goals with effectiveness, efficiency, and 86 
satisfaction in a specified context of use.”[20] According to ISO, effectiveness 87 
describes the ability of users to complete pre-determined tasks during a usability test 88 
while efficiency refers to the level of resource required to perform these tasks.[20] 89 
Satisfaction relates to the subjective views of users based on their test 90 
experience.[20] 91 
When assessing these three aspects of usability, consideration needs to be given to 92 
the context of use.[21-23] Participant characteristics such as age and health status 93 
would therefore determine the specific methods to employ and the metrics to 94 
measure during a usability study.[21-23] Patients with CKD tend to be older 95 
adults[24, 25] who may have age-related physical and cognitive limitations.[26, 27] 96 
They may also experience a number of debilitating CKD-related symptoms such as 97 
fatigue and cognitive impairment which could significantly affect their ability to use an 98 
ePROM system.[28, 29] These age and health-related issues need to be taken into 99 
account when designing and testing an ePROM system for this patient group. It is 100 
also crucial that patients iteratively [30] assess the usability of the system so that 101 
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usability issues may be detected and addressed prior to full-scale implementation 102 
[31]  in other to reduce attrition rates.[26, 32, 33]  103 
 104 
Development of the Renal ePROM 105 
 106 
At the start of this project, a systematic review of PROMs used in patients with CKD 107 
was conducted. The review found evidence to support the use of the 80-item kidney 108 
disease quality of life-short form (KDQOL-SF) [34] and the 36-item kidney disease 109 
quality of life-36 (KDQOL-36).[35] However, very few studies validated these two 110 
measures in our target population (stages 4 and 5 CKD).[35, 36] The review also 111 
identified the IPOS-Renal (11 items), [37] which was undergoing validation at the 112 
time.  113 
A patient advisory group evaluated the acceptability, burdensomeness and 114 
relevance of the KDQOL-SF, KDQOL-36 and the IPOS-Renal. The patients 115 
expressed a preference for the KDQOL-36 and IPOS-Renal as they were brief and 116 
easy to understand.[38] Their preference for shorter, and therefore less burdensome, 117 
questionnaires is understandable given that patients with advanced CKD often suffer 118 
from fatigue and lack of energy, [1, 3] which may make completing longer 119 
questionnaires KDQOL-SF on a regular basis a significant challenge. Therefore, we 120 
adapted the KDQOL-36 and the IPOS-Renal for the renal ePROM system. In order 121 
to comply with the questionnaire developers’ terms of use, we had to keep the user 122 
interface as similar as possible to the original paper versions. However, we still 123 
followed a number of recommendations for web-design for elderly users [39] and the 124 
interface was designed to be simple and straightforward to minimise patient burden. 125 
For example, we avoided the need for pull down menus, double clicking and kept the 126 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
number of pages to click through to a minimum, as ability to precisely position the 127 
computer cursor has been shown to diminish with age.[26, 39, 40] Older individuals 128 
may also have issues with visual acuity, contrast sensitivity and colour 129 
discrimination.[41] Therefore the colour palette was restricted and the text for the 130 
questionnaires was presented on a neutral background using black Arial font, which 131 
is an easy to read sans-serif font (See Fig 1).  132 
The electronic adaptation was performed by a senior .Net developer from the  133 
Application Development team, University Hospitals Birmingham NHS Foundation 134 
Trust (UHB) using the DataCollector application developed in-house (See Figs. 1 - 135 
3).[38] The DataCollector has two sections - the ‘back end’ of the application is the 136 
administrative section which is used to create and manage questionnaires while the 137 
‘front end’ is the user section which enables patients and/or staff to answer 138 
questionnaires. The DataCollector was developed using Microsoft.Net technology, 139 
mainly ASP.Net Webforms, C#, Entity framework and SQL Server. Bootstrap 140 
framework was used to make the ‘front end’ as responsive as possible to enhance its 141 
performance on electronic devices and on most of the main web browsers. The 142 
DataCollector was embedded in myhealth@QEHB, a secure electronic patient portal 143 
also developed by the Application Development and Informatics team (See Figure 144 
3).[42]  145 
 146 
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 147 
Fig. 1. Screenshot of the electronic KDQOL-36 questionnaire. 148 
 149 
 150 
Fig. 2. Screenshot of the progress buttons. 151 
 152 
 153 
 154 
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 155 
Fig. 3. Screenshot of the myhealth@QEHB login page. 156 
157 
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Methods 158 
 159 
This usability study was designed and conducted according to the study protocol, 160 
[38] following guidelines and recommendations provided by the International Society 161 
for Pharmacoeconomics and Outcomes Research (ISPOR), [10, 19] and the United 162 
States Department of Health and Human Service.[43] The study was approved by 163 
the West Midlands Edgbaston Research Ethics Committee (Reference 17/WM/0010) 164 
and received Health Research Authority (HRA) approval on 24 February 2017. 165 
Project authorisation was granted by UHB Research and Design (R & D) in April 166 
2017 (RRK6050).  167 
Study participants  168 
 169 
Eight adult patients with advanced CKD stages 4 & 5 who are at risk of rapid clinical 170 
deterioration to renal failure [38] were recruited from the UHB nephrology service 171 
between May and July 2017. We targeted this group of patients as we hypothesised 172 
that they are likely to benefit the most from using the ePROM system which may 173 
help delay disease progression. Patients with acute kidney injury were excluded 174 
because their underlying medical condition may not be CKD. Patients who have 175 
debilitating co-morbidities or are judged by their clinicians to be severely unwell were 176 
also excluded as it would be unethical to subject them to the demands of the study. 177 
The research team is currently working on a separate project focused on patients 178 
receiving dialysis whose lived experiences and care needs differ from those of 179 
advanced CKD patients. 180 
 181 
 182 
 183 
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Recruitment process 184 
 185 
A research nurse from the Renal services at UHB screened patient records and 186 
approached eligible patients in clinic.[38] The nurse informed these patients about 187 
the study, provided them information sheets and responded to their queries. The 188 
patients were contacted by the nurse after 48 hours to ascertain that they had read 189 
the information sheet and wished to participate in the study. The research nurse 190 
gave the interviewer (OLA), in person, the contact details of patients who expressed 191 
an interest in the study and verbally agreed to OLA contacting them. OLA 192 
telephoned these patients, confirmed their wish to participate in the study, answered 193 
further queries, and arranged a mutually suitable date and time for the testing. 194 
Written informed consent was obtained from all the participants and study data was 195 
anonymised. 196 
 197 
Testing procedure 198 
The interviewer (OLA) conducted one-to-one test sessions with participants at the 199 
Institute of Translational Medicine (ITM) using the demonstration version of the 200 
Renal ePROM system. Participants completed the questionnaires using desktop 201 
computers and received as little assistance as possible while OLA noted verbal and 202 
non-verbal cues. Family members were allowed to sit in on the test sessions as we 203 
are aware that in real life home settings, they may be present when patients 204 
complete their ePROMs.  205 
At the start of the sessions, OLA presented the participants with an a priori scenario. 206 
Participants were asked to assume they were reporting their health status between 207 
clinic appointments from home. They were told to recall and report their health over 208 
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the past 4 weeks for the KDQOL-36 and within the last week for the IPOS-Renal.  209 
Each participant had 11 tasks to complete during the test session (See Appendix). 210 
Participants were asked during their session to assume that they needed a break, for 211 
whatever reasons, before continuing their test session. They were told they needed 212 
to save their responses up to that point or lose them as the system would time out 213 
during the break. Patients were also told just after commencing the IPOS-Renal to 214 
assume they had made an error on the preceding KDQOL-36 and needed to go back 215 
to the questionnaire to correct it. The purpose of this scenario was to provide a 216 
defined context for the test sessions, assess the intuitiveness of the system and the 217 
functionality of the progress buttons. 218 
In order to assess efficiency, the time taken to complete each questionnaire was 219 
recorded for each participant. The number of errors per participant and the amount 220 
and nature of assistance required during the test sessions were also recorded in 221 
order to assess effectiveness. Non-critical errors were regarded as errors 222 
participants successfully addressed themselves following instructions from the 223 
interviewer. Critical errors were those that required the interviewer to take over and 224 
rectify such as the accidental closure of questionnaire page.  225 
The sessions were followed by brief audio-recorded interviews during which 226 
participants were asked specific questions on their views and opinions of the 227 
ePROM system, the issues or difficulties they encountered during their test session 228 
and their access to and use of electronic devices/internet. These interviews were 229 
scheduled to last no more than 10 minutes in order to minimise participant burden. 230 
Participants were also asked 4 questions designed to rate their satisfaction with the 231 
system and its usability on a 5-point scale (1 representing poor/never and 5 232 
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representing excellent/yes). The 10-item System Usability Scale (SUS) [22] and 233 
other usability scales were considered, but in the end we concluded that a much 234 
shorter set of four questions would be less burdensome for participants who also had 235 
to complete the 46-item ePROM questionnaire. 236 
Moderating technique 237 
A combination of Concurrent Think Aloud (CTA) and Retrospective Probing (RP) 238 
moderating techniques were used.[44] Participants were encouraged to vocalise 239 
their thoughts during the test sessions and had brief interviews after their 240 
session.[44] Combining these two techniques made it possible to gather ‘real time’ 241 
feedback which were subsequently explored during the interviews.[43] 242 
Data Analysis 243 
 244 
Continuous variables such as age and time required for completion of ePROMs were 245 
presented as means. Participant ratings for the four usability questions were used to 246 
calculate a mean score. Categorical variables such as errors (critical and non-247 
critical) were presented as percentages (%).  Participants’ comments during the 248 
interviews were extracted as quotes and categorised under 'general impressions' 249 
and 'issues'. These categories of comments were presented in a table along with the 250 
interviewer’s observations. 251 
252 
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Results 253 
 254 
Table 1 presents the participant demographics. The eight participants had a mean 255 
age of 64.3 years (range: 36 - 87 years). 256 
 257 
Table 1. Patient demographics (n = 8) 
Variable n 
Age a  
   <50 
   >50 
 
1  
7  
Gender  
   Female 
 
4  
Ethnicity  
   British-White 
   British-Asian 
   Irish-White 
  
5  
2  
1  
Occupation 
   Retired 
   Employed 
   Unemployed  
 
6  
1  
1  
Computer/internet usage 
   Often b 
   Occasionally c 
   Rarely d 
 
6  
1  
1  
a Mean: 64.3 years, range: 36 - 87 years 258 
b
 Often: 4 – 7 days per week 259 
c
 Occasional: 1 - < 3 days per week 260 
d Rare: <1 day a week 261 
 262 
 263 
Assessment of efficiency 264 
Table 2 presents the time requirements by the participants. The mean time required 265 
to complete the two questionnaires was 15.9 minutes (range = 8 - 34 minutes). The 266 
mean time required to complete the KDQOL-36 was 10 minutes (range = 5 - 20 267 
minutes) while the mean time to complete the IPOS-Renal was 5.9 minutes (range = 268 
3 - 14 minutes).  269 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
14 
 
Participants were divided into two groups solely for the purpose of analyzing the 270 
data. Group 1 consisted of the six participants that used the internet/electronic 271 
devices often (4 – 7 days per week), while Group 2 comprised of the one occasional 272 
user (1 - < 3 days per week) and the one rare user (<1 day a week). Participants in 273 
Group 1 required a mean time of 8.5 minutes to complete the electronic KDQOL-36 274 
while those in Group 2 took a mean time of 14.5 minutes. The participant who rarely 275 
used the internet/electronic devices took the longest time to complete both 276 
questionnaires. 277 
 278 
Assessment of effectiveness 279 
There were five non-critical errors and one critical error. The five non-critical errors 280 
were due to omissions and participants addressed these themselves after being told 281 
by the interviewer to scroll up the questionnaires and check for omissions. The 282 
critical error which was recorded for participant 8 required the interviewer to take 283 
over the mouse and locate the cursor before the participant could progress with the 284 
tasks. A list of the tasks is provided in the Appendix. 285 
Table 2. Time requirements (mean and standard deviation) and error information 
 All participants   
(n = 8) 
 
Group 1*  
Often (n = 6 ) 
Group 2* 
Occasionala & rareb (n = 2) 
mean time   KDQOL-
36 
10.0 (+ 1.6)  8.5 (+ 1.1)  14.5 (+ 5.5) 
Mean time IPOS-
Renal 
5.9 (+ 1.2) 4.7 (+ 0.4) 9.5 (+ 4.5) 
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Total mean time  15.9 (+ 2.8) 13.2 (+ 1.5) 24.0 (+ 5.0) 
Non-critical errors 5   (5.7%) 3   (4.5%) 2   (9.1%) 
Critical errors 1   (1.1%) 0   (0.0%) 1   (4.5%) 
* Grouping based on frequency of computer/internet use 286 
a
 Participant 4 287 
b
 Participant 8 288 
 289 
Assessment of satisfaction and opinions of the renal ePROM system 290 
Table 3 presents participants’ rating of the usability and their satisfaction with the 291 
Renal ePROM.  The mean scores for individual questions were high and the average 292 
usability and satisfaction score was 4.6 (5-point scale).  293 
Table 3. Usability and satisfaction with Renal ePROM (mean and standard 
deviation) 
Question Average score  
(5-point scale) 
Ease of use and navigation  4.6 (+ 0.2) 
Satisfaction with content 4.5 (+ 0.2) 
Satisfaction with visual display 4.5 (+ 0.3) 
Likelihood of using again or recommending to others 4.9 (+ 0.1) 
Average usability and satisfaction score  4.6 (+ 0.1) 
 294 
Table 4 presents the participants’ comments and OLA’s observations. The interviews 295 
lasted on average 5 minutes (range of 4 – 10 minutes). The general impression of 296 
the Renal ePROM was positive with all the participants commenting on its simplicity 297 
and ease of use. Two participants recommended an increase in font sizes.  298 
The scenario given to the participants helped OLA assess how intuitive the Renal 299 
ePROM was and the functionality of the progress buttons. The progress buttons 300 
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were fully functional and all the participants correctly identified the ‘previous’ button 301 
to go back to the KDQOL-36 questionnaire. When invited to take a break all except 302 
one participant (participant 8) identified the correct button to ‘save and continue 303 
later’.   304 
Table 4. Participants' comments and interviewer's observations 
   Comments 
Overall impression 
of the Renal 
ePROM V1 
(Participants) 
• “Simple, straightforward and easy to use” (Participant 1) 
• “It is quite good really. It is easy enough” (Participant 2) 
• “Completing this was easy. On a regular basis it will be convenient 
to use a smartphone.” (Participant 3) 
• “Easy to use.” (Participant 4) 
• “Clear and easy to understand. It didn’t appear to have any trick 
questions.” (Participant 5) 
• “Clear and easy” (Participant 6) 
• "The questions were straightforward." (Participant 7) 
• "Nothing complicated…its controlling the mouse…(laughs)..” 
(Participant 8) 
Issues 
(Participants) 
• “The print is a bit small. That thing (mouse) is a bit fiddly to use” 
(Participant 4) 
• “It (the fonts) could have been a bit bigger because you have got 
plenty of room on it” (Participant 2) 
• “Can’t see the options after a while” (please see the first 
observation below). (Participant 6) 
 
 Observations 
Interviewer • Beyond a certain point, the descriptions for the response options 
do not remain visible at the top for the group of KDQOL-36 
questions that were set in a matrix format. The participants needed 
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to scroll up to see the descriptions. This was an issue for those 
who struggled to use the mouse (Participants 4, 8). 
• Five participants (Participants 1, 4, 5, 7, 8) unintentionally omitted 
questions and assumed the progress buttons were not functioning 
when they could not proceed. The interviewer had to tell them to 
scroll up and check for omissions.  
• Three of the participants (one frequent user (Participant 1), the 
occasional user (Participant 4) and the rare user (Participant 8) 
had varying levels of dexterity issues controlling the mouse. Two of 
them were able to scroll up and down the pages without assistance 
but with some difficulty while the third (rare user) had more 
difficulty controlling the cursor and needed the interviewer to locate 
the cursor on two occasions in order to continue with the tasks.  
• Participant 7, who was accompanied by their partner, paused 
significantly when answering questions on burden to family, sex life 
(KDQOL-36) and feelings of depression (IPOS-Renal).  
 305 
 306 
307 
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Discussion 308 
 309 
Summary of main findings 310 
This article reports the usability testing of the Renal ePROM system in a group of 311 
patients with advance CKD. Our study suggests that patients with advanced CKD 312 
may find the Renal ePROM system easy to use and acceptable for reporting their 313 
symptoms remotely. Error levels were relatively low and mostly due to non-critical 314 
omissions. Overall, the system was found to be efficient and effective despite the few 315 
issues identified. 316 
Findings in relation to existing literature 317 
The opinion of study participants’ that the renal ePROM system is acceptable and 318 
easy to use is in keeping with reports from well-designed ePROM-related usability 319 
studies.[45-48] Participant perception is very important as it has been demonstrated 320 
that perceived ease of use of an information technology (IT) system or product, by 321 
the end user, has a direct effect on its perceived usefulness and subsequent 322 
usage.[45, 49]  323 
Our study participants had a mean age of 64.3 years which is approximately the 324 
mean age of our target population.[25, 50, 51] All except one participant were >50 325 
years old and five of them reported a similar usage of the internet/electronic devices 326 
as the 36-year-old participant. Their computer literacy levels also matched the 327 
current levels expected for individuals within this age group.[52] Our study confirms 328 
the finding by Gatto et al. that individuals aged 55 and over possess significantly 329 
higher levels of computer literacy with each passing decade as people take their IT 330 
skills into retirement.[52] Although we had a mixture of male and female participants, 331 
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there were no indications that gender had an effect on their usability experiences. 332 
We did not observe any gender differences in access or use of the internet/electronic 333 
devices which is in keeping with findings in literature.[52, 53]  334 
Participants required a mean time of 10 minutes to complete the electronic version of 335 
the KDQOL-36 which is lower than the mean time of 15 minutes participants required 336 
to complete the paper format in the study by Thaweethamcharoen et al.[54] It was 337 
not surprising that the participants who recorded the longest completion times also 338 
had the least experience of using computers as reported by previous studies.[10, 55, 339 
56] However, their completion times may reduce over time as Erharter et al.[57] 340 
showed that with regular use, the time required by patients' to complete an ePROM 341 
may reduce by as much as 30%.[57] 342 
Implications for ePROM developers, programmers and healthcare professionals 343 
The omissions by the participants may be due to eyesight issues (the participants 344 
wore glasses) or cognitive impairment which may be age-related [26, 27, 41] or 345 
associated with advanced CKD.[28, 29] The font size (12pt) might have been a 346 
contributing factor [39, 41, 58] as it was suggested by two of the participants that we 347 
increase the font sizes. Programmers and usability moderators should therefore 348 
inquire directly about the suitability of font sizes during usability tests. The dexterity 349 
issues observed in the occasional and rare users could be due to their limited 350 
experience of using the internet and computer. It could also be due to age-related 351 
joint problems such as arthritis.[27, 39, 40] These patients might have found it easier 352 
to use a touch screen tablet instead of a mouse controlled desktop.[39, 40] 353 
Programmers and usability moderators should ensure that various electronic 354 
platforms are tested at some point during the development of an ePROM system. 355 
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It was interesting to note that when asked about their use of the internet, virtually all 356 
the participants initially replied ‘not often or rarely’ but when probed further, all except 357 
two visited websites such as YouTube and used social media websites and 358 
applications such as Facebook, Twitter, WhatsApp on a regular basis. This suggests 359 
that some individuals may unwittingly under-report their engagement with information 360 
technology as they do not consider the use of online entertainment or social media 361 
as 'surfing' the internet. Developers need to be cognisant of this perception of 362 
information technology when designing ePROM systems for this age group as it 363 
could determine how it is perceived and adopted.[45, 49] 364 
The noticeable hesitation by a participant during their test session, which was 365 
attended by their partner, raises the issue of external influences on the information 366 
patients may provide especially if completing the Renal ePROM at home. Various 367 
studies have shown positive and negative influences of the family and friends on the 368 
actions of patients living with chronic illnesses.[59-63] There is also a tendency for 369 
proxy reports of a patient’s health status or function to be worse than self-370 
reports.[64-67] While these influences cannot be removed entirely, healthcare 371 
professionals can minimise them by educating patients and their families on the 372 
importance of self-completion.  373 
Some patients may consider certain questions very personal or may feel 374 
uncomfortable or embarrassed admitting that they have problems in some domains 375 
of HRQOL. Bataclan and Dial [68] reported significant amounts of missing data for 376 
questions relating to sexual function which shows reluctance among patients to 377 
answer certain questions.[68] Therefore, healthcare professionals need to be aware 378 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
of these important but potentially sensitive issues and devise practical ways of 379 
addressing them.  380 
Limitation of the study 381 
The key limitation of this study is that test sessions were conducted on-site in an 382 
interviewer-controlled setting. There is a possibility that participants’ usability 383 
performance and experience may be different at home without the instructions and 384 
prompts given by the interviewer. 385 
Other issues  386 
There is an on-going debate about sample sizes for usability testing.[69-73] The 387 
current recommendation by ISPOR is 5 to 10 participants for simple ePROM 388 
systems.[10] Given that the patient-facing side of the ePROM system was designed 389 
to be as simple and as straightforward as possible, a sample size of eight 390 
participants was deemed adequate and exceeds the minimum number of five 391 
recommended for this type of test.[10, 69-73] A number of published usability studies 392 
have also successfully used sample sizes similar to ours.[74-76]  393 
While we did not use the SUS for this study, it should be noted that there are clear 394 
parallels between the four questions and the SUS scale. For instance the first 395 
question of our scale which addressed the ease of use and navigation is closely 396 
related to questions 2 & 3 from the SUS scale ("I found the system unnecessarily 397 
complex" and "I thought the system was easy to use"). Gray et al. decided not to use 398 
an existing scale opting for a more qualitative approach in their usability study.[76] 399 
Cornet et al. suggested that qualitative methods might actual provide better results in 400 
older adults.[26] The SUS and other usability scales will be considered for use in a 401 
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future pilot study with a much larger sample size, where their statistical potential 402 
could be maximised.  403 
Planned modifications to the ePROM system 404 
The findings from this test will be used to improve the system. Therefore, we will 405 
increase the font sizes to make the questionnaires easier to read. The descriptions 406 
for the response options will be redesigned as a floating panel which will remain 407 
visible as users scroll down the questionnaires. This will reduce the need for scrolling 408 
the page. An alert will be incorporated into the system to inform users about 409 
omissions and their specific locations if possible. As stated in the study protocol, [38] 410 
the system will be optimised for use on touch-screen tablets and mobile phones. All 411 
the versions will be tested in the next cycle and after implementation, patients will be 412 
able to use the digital platform of their choice. The final version will be tested 413 
remotely (participants’ homes) via the personal health record system at UHB. A full 414 
validation study will be conducted later to ascertain the reliability and validity of the 415 
ePROMs in our target patient group.  416 
A/B testing will be conducted for future system upgrades, to compare the upgrade 417 
version with the current version, following published guidelines.[77] A much larger 418 
patient sample will be utilised to adequately power the statistical analysis of the test 419 
data.[78] The results from this large scale analysis will provide valuable insights on 420 
user preferences and behaviour which will be used to further improve the 421 
system.[77] 422 
Conclusion 423 
Although the digital divide between older and younger populations is decreasing,[79] 424 
older individuals have a tendency to discontinue the use of health information 425 
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technology.[80] In order to minimise post implementation attrition rates, we have 426 
involved patients from our target population in the design and development of the 427 
ePROM system.[32] We have also conducted this usability test with patients, who 428 
represent our target users [33] in order to assess the acceptability and usability of 429 
the Renal ePROM system.[10, 19]  430 
As access and use of the internet and electronic devices increase, the use of 431 
ePROMs could assist clinicians with the monitoring of HRQOL/symptoms of 432 
deterioration in patients with CKD.[13]  This may provide clinicians the opportunity to 433 
intervene early and possibly delay disease progression. It also has the potential to 434 
facilitate patient-clinician communication and enhance patient-centred care.[11, 13] 435 
436 
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Appendix  646 
List of tasks 
Task  Description 
1 “Choose ‘Main Questionnaire’ from the ‘Application’ menu.” 
2 “Click Submit.” 
3 “Can you see the section ‘New Available’? Please click the link ‘Your 
Health Today’.” 
4 “Please answer the questions.” 
5 “Imagine you now need to stop for a bit. What do you do? Find the 
‘save to edit later’ button and click.” 
6 “From the menu page, can you find the saved questionnaire? Click the 
saved questionnaire.” 
7 “Please complete the questionnaire.” 
8 “Proceed to the next questionnaire.” 
9 “Please complete the questionnaire.” 
10 “Click the submit button please.” 
11 “Can you see a page saying ‘Success’? Please logout.” 
 647 
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• A renal ePROM system may assist clinicians with the management of patients 
with advanced chronic kidney disease. 
• Usability testing is crucial during the development of an ePROM system for 
older patients with chronic medical conditions. 
• Patients with advanced CKD may find the system acceptable for reporting their 
symptoms and health-related quality of life. 
• Some individuals may experience dexterity issues and family members may 
influence the use of the system real life. 
• Individuals within this age group may unwittingly under-report their 
engagement with information technology. 
 
